The diabetic wound is one of the severe complications of diabetes mellitus, accounting for 20 % of limb amputations in diabetic patients. This creates a need to search for newer natural compounds to target the different molecular pathways of diabetic wounds to accelerate the repair. The phenylethanoid glycosides (PhGs) isolated from Clerodendrum glandulosum (CG) have been shown to exhibit antioxidant, antimicrobial, and anti-inflammatory properties but have never been explored for diabetic wound healing. Thus, this study focuses on exploring the diabetic wound-repairing properties of PhGs through in-silico approaches. The PhGs present in CG were identified through extensive literature searching, which were further subjected to database searching in BindingDB, TargetNet, PharmMapper, Super-PRED, and Swiss Target Prediction to find the potential targets, which included PRKCA, PRKCG, PRKCZ, TDP1, and Pol. Subsequently, these targets were used to determine the disease IDs related to diabetic wounds from databases such as DisGeNET, Gene Expression Omnibus, GeneCards, and OMIM. A network was established using Cytoscape to study the relationship among the PhGs, the protein targets, and their associated disease IDs. The top twenty molecular pathways associated with the target proteins were determined using the ShinyGO database. Genetic enrichment analysis showed that the Sphingolipid signalling pathway included the maximum number of genes and had the lowest false discovery rate value, which concluded that this pathway is the potential target of the PhGs. PRKCA and PRKCZ were found to be the only two genes involved in this pathway, and thus, molecular docking was used to evaluate the binding affinity of the PhGs with the proteins. Docking scores were between -13.2859 and -5.10928, suggesting a strong molecular interaction between the PhGs and their targets. Thus, it is concluded that PhGs present in CG can be the potential compounds to treat diabetic wounds; however, further in-vitro and in-vivo investigations are necessary.